HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk

Erlich, Henry, Valdes, Ana Maria, Noble, Janelle, Carlson, Joyce A., Varney, Mike, Concannon, Pat, Mychaleckyj, Josyf C., Todd, John A. +6 more·2008·Diabetes
DOI 10.2337/db07-1331

Cited by (694)

Items 401–500 of 694

  1. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation
    Darius Schneider, Alexandra Kretowicz, Matthias G. von Herrath · 2012 · Diabetes Obesity and Metabolism
  2. Dendritic Cell–Dependent In Vivo Generation of Autoregulatory T Cells by Antidiabetogenic MHC Class II
    Sue Tsai, P. Serra, X. Clemente-Casares, R. Slattery, P. Santamaria · 2013 · Journal of Immunology
  3. The Missing Heritability in T1D and Potential New Targets for Prevention
    Brian G. Pierce, Ryan A. Eberwine, Janelle Annette Noble, Michael Habib, Hennady P. Shulha, Zhiping Weng, Elizabeth P. Blankenhorn, John P. Mordes · 2013 · Journal of Diabetes Research
  4. HLA class I and II alleles are associated with microvascular complications of type 1 diabetes
    Ettie M. Lipner, Yaron Tomer, Janelle Annette Noble, Maria Cristina Monti, J.T. Lonsdale, Barbara Corso, W.C.L. Stewart, David A. Greenberg · 2013 · Human Immunology
  5. MHC–environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth
    K. Badenhoop, H. Kahles, C. Seidl, O. Kordonouri, E. R. Lopez, M. Walter, S. Rosinger, A. Ziegler, B. Böhm · 2009 · Diabetes, obesity and metabolism
  6. Autoimmune (Type 1) Diabetes
    Ida Lindbladh, Agnes Andersson Svärd, Åke Lernmark · 2019 · Elsevier eBooks
  7. Feline Diabetes Mellitus
    Claudia E Reusch · 2015 · Elsevier eBooks
  8. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis
    Lu You, Lauric A. Ferrat, Richard A. Oram, Hemang M. Parikh, Andrea K. Steck, Jeffrey P. Krischer, MARIA JOSE REDONDO, the Type 1 Diabetes TrialNet Study Group · 2024 · Diabetologia
  9. A structural basis of T cell cross-reactivity to native and spliced self-antigens presented by HLA-DQ8
    Mai T. Tran, Jia-Jia Lim, T. Loh, S. Mannering, J. Rossjohn, Hugh H. Reid · 2024 · Journal of Biological Chemistry
  10. Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention
    Quin Yuhui Xie, Sean Oh, Anthony Wong, Christopher Yau, Kevan C. Herold, Jayne S. Danska · 2023 · Science Translational Medicine
  11. Asian-type DEL (RHD*DEL1) with an allo-anti-D: a paradoxical observation in a healthy multiparous woman
    H. Ohto, S. Ito, Kshitij Srivastava, Y. Ogiyama, M. Uchikawa, K. Nollet, W. Flegel · 2023 · Transfusion
  12. Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China
    Yichen Liu, Hong Liu, Shaoli Zhao, Ke Chen, Ping Jin · 2023 · Frontiers in Immunology
  13. Next Generation Sequencing Identifies the HLA-DQA1*03:03 Allele in the Type 1 Diabetes Risk-Associated HLA-DQ8 Serotype
    Jürgen Enczmann, Vera Balz, Maximilian Hoffmann, Sebastian Kummer, Christina Reinauer, Carsten Döing, Katharina Förtsch, Alena Welters, Ertan Mayatepek, Thomas Meißner et al. · 2021 · Genes
  14. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance
    Sivasangari Balakrishnan, Prabhakaran Kumar, Bellur S. Prabhakar · 2020 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  15. Association of HLA-DRB1 and -DQ alleles and haplotypes with Type 1 Diabetes in Jordanians.
    Sawsan I. Khdair, Wassan Jarrar, Y. Jarrar, Safa’a Bataineh, O. Al-Khaldi · 2019 · Endocrine, Metabolic & Immune Disorders - Drug Targets
  16. Targeting antigen presentation in autoimmunity
    Jason R. Lees · 2018 · Cellular Immunology
  17. Aetiology of type 1 diabetes: Physiological growth in children affects disease progression
    Oskar Skog, Olle Korsgren · 2017 · Diabetes Obesity and Metabolism
  18. Genetics of Diabetes and Diabetic Complications
    Rashmi B. Prasad, Emma Ahlqvist, Leif Groop · 2018 · Endocrinology
  19. Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex
    Matthew L. Bettini, Maria Bettini · 2017 · Frontiers in Endocrinology
  20. Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases
    Christine Brütting, Alexander Emmer, Malte Erich Kornhuber, Martin Sebastian Staege · 2017 · BioMed Research International
  21. Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success
    Niels V. Rekers, Matthias G. von Herrath, Johnna D. Wesley · 2015 · Clinical Immunology
  22. Comprehensive identification of high-frequency and co-occurring Mafa-B, Mafa-DQB1, and Mafa-DRB alleles in cynomolgus macaques of Vietnamese origin
    F. Ling, M. Zhuo, Chao Ni, Gui-Qing Zhang, Tao Wang, Wai Li, Li-qiong Wei, Hong-Li Du, Ju-Fang Wang, Xiao-Ning Wang · 2012 · Human Immunology
  23. Type 1 diabetes
    P. Burn · 2010 · Nature reviews. Drug discovery
  24. Genetic variation within the HLA class III influences T1D susceptibility conferred by high risk HLA haplotypes
    A. Valdés, G. Thomson, L. Barcellos · 2010 · Genes and Immunity
  25. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans
    DAVID V. SERREZE, Marijke Niens, John Kulik, Teresa P. DiLorenzo · 2016 · Methods in molecular biology
  26. Disease-modifying pharmacological treatments of type 1 diabetes: Molecular mechanisms, target checkpoints, and possible combinatorial treatments
    Liudmila Kosheleva, Daniil Koshelev, Francisco Alejandro Lagunas‐Rangel, Shmuel Levit, Alexander Rabinovitch, Helgi B. Schiöth · 2025 · Pharmacological Reviews
  27. A Review of Stage 0 Biomarkers in Type 1 Diabetes: The Holy Grail of Early Detection and Prevention?
    Măriuca Mănescu, I. Mănescu, A. Grama · 2024 · Journal of Personalized Medicine
  28. Autoimmune polyglandular syndrome type 4: experience from a single reference center
    E. Gatta, V. Anelli, E. Cimino, E. Di Lodovico, E. Piovani, I. Zammarchi, G. Gozzoli, V. Maltese, M. Cavadini, B. Agosti et al. · 2023 · Frontiers in Endocrinology
  29. Prevalence of haplotype DQ2/DQ8 and celiac disease in children with type 1 diabetes
    Agnieszka Zubkiewicz‐Kucharska, Tatiana Jamer, Joanna A. Chrzanowska, Katarzyna Akutko, Tomasz Pytrus, Andrzej Stawarski, Anna Noczyńska · 2022 · Diabetology & Metabolic Syndrome
  30. Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab
    Yutaka Natori, Eisaku Sasaki, Shu Soeda, Shigenori Furukawa, Yusuke Azami, Emi Tokuda, Takashi Kanbayashi, Shigehira Saji · 2020 · Journal for ImmunoTherapy of Cancer
  31. Adult‐onset type 1 diabetic patients with less severe clinical manifestation have less risk DR‐DQ genotypes than childhood‐onset patients
    Wenqian Ren, Daizhi Yang, Ziyu Jiang, Yingxin Xian, Qianwen Huang, Sihui Luo, Xueying Zheng, Jinhua Yan, Wen Xu, Bin Yao et al. · 2020 · Diabetes/Metabolism Research and Reviews
  32. Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma
    Chenan Zhang, A. D. de Smith, I. Smirnov, J. Wiencke, J. Wiemels, J. Witte, K. Walsh · 2017 · Journal of Neuro-Oncology
  33. Diabetes mellitus in childhood: an emerging condition in the 21st century
    Thaís Della Manna, Nuvarte Setian, Roberta Diaz Savoldelli, Dulce Rondina Guedes, Hílton Kuperman, Hamilton Cabral Menezes Filho, Leandra Steinmetz, Louise Cominato, Vaê Dichtchekenian, Durval Damiani · 2016 · Revista da Associação Médica Brasileira
  34. Family-based association study of HLA class II with type 1 diabetes in Moroccans.
    A. D. Bourhanbour, N. Benseffaj, S. Ouadghiri, R. Razine, A. Touzani, A. Belafraj, M. Essakalli · 2015 · Pathologie et biologie
  35. Timing of complementary food introduction and age at diagnosis of type 1 diabetes: the SEARCH nutrition ancillary study (SNAS)
    Tessa Crume, Jamie Crandell, J M Norris, Dana Dabelea, Mary T. Fangman, David J. Pettitt, Lawrence M. Dolan, Beatriz L. Rodríguez, R O'Connor, Elizabeth J. Mayer‐Davis · 2014 · European Journal of Clinical Nutrition
  36. Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium.
    Peter R. Baker, P. Fain, H. Kahles, Li-Ping Yu, J. Hutton, J. Wenzlau, M. Rewers, K. Badenhoop, G. Eisenbarth · 2012 · Journal of Clinical Endocrinology and Metabolism
  37. "I am pregnant and my husband has diabetes. Is there a risk for my child?" A qualitative study of questions asked by email about the role of genetic susceptibility to diabetes
    S. V. van Esch, M. Cornel, F. Snoek · 2010 · BMC Public Health
  38. Clinical features, biochemistry, and <i>HLA</i> ‐ <i>DRB1</i> status in youth‐onset type 1 diabetes in Mali
    Besançon, Stéphane, Govender, Denira, Sidibé, Assa Traore, Noble, Janelle Annette, Togo, Amagara, Lane, Julie Ann, Mack, Steven John, Atkinson, Mark A., Wasserfall, Clive Henry, Kakkat, Faizy et al. · 2022 · Pediatric Diabetes
  39. Association between alleles, haplotypes, and amino acid variations in HLA class II genes and type 1 diabetes in Kuwaiti children
    M. Dashti, R. Nizam, S. Jacob, H. Alkandari, E. Al-Ozairi, T. Thanaraj, F. Al-Mulla · 2023 · Frontiers in Immunology
  40. Monitoring immunomodulation strategies in type 1 diabetes
    Balasubramanian Krishnamurthy, Matthew Lacorcia, Thomas W. H. Kay, Helen E. Thomas, Stuart I. Mannering · 2023 · Frontiers in Immunology
  41. Transcriptomic profiling reveals gene expression in human peripheral blood after exposure to low-dose ionizing radiation
    Fang Fang, Xiaoling Yu, Xiaochun Wang, Xiaojun Zhu, Lantao Liu, Rong Li, Dongsheng Niu, Jue Li · 2021 · Journal of Radiation Research
  42. Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes
    Hai P. Nguyen, Perrin Guyer, R. Ettinger, E. James · 2021 · Biomedicines
  43. Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes
    Ada Admin, Lue Ping Zhao, George K. Papadopoulos, William W. Kwok, Antonis K. Moustakas, George P. Bondinas, Annelie Carlsson, Helena Elding Larsson, Johnny Ludvigsson, Claude Marcus et al. · 2020 · Diabetes
  44. Molecular mimicry between varicella, measles virus and Hsp60 in type 1 diabetes associated HLA-DR3/DR4 molecules.
    F. Meziane, Majda Dali-Sahi, Nouria Dennouni-Medjati, H. Boulenouar, Youssouf Kachekouche, Yasmine Benslama, Y. Harek · 2020 · Diabetes & metabolic syndrome
  45. Association of HLA‐DR‐DQ alleles, haplotypes, and diplotypes with type 1 diabetes in Saudis
    Nezar Eltayeb-Elsheikh, E. Khalil, M. Mubasher, A. Aljurayyan, H. Alharthi, Waleed H Omer, I. Elghazali, S. Sherbeeni, Mohammed A. AlGhofely, J. Ilonen et al. · 2020 · Diabetes/Metabolism Research Reviews
  46. Biochemical, serological, and genetic aspects related to gene HLA‐DQB1 and its association with type 1 diabetes mellitus (T1DM)
    G. Singh, Mehboob Ahmed, M. Zaid, S. Hasnain · 2020 · Molecular Genetics & Genomic Medicine
  47. Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in Taiwan
    Yi‐Ching Tung, Cathy S.J. Fann, Chien-Ching Chang, Chen‐Chung Chu, Wei‐Shiung Yang, Wuh‐Liang Hwu, Pei‐Lung Chen, Wen–Yu Tsai · 2018 · Pediatric Diabetes
  48. The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype
    Christina Reinauer, Joachim Rosenbauer, Christina Bächle, Christian Herder, Michael Roden, Sian Ellard, Elisa De Franco, Beate Karges, Reinhard Walter Holl, Jürgen Enczmann et al. · 2017 · Genes
  49. Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY
    Inés Urrutia, Rosa Martı́nez, Tamara López-Euba, Teresa Velayos, Idoia Martinez de la Piscina, José Ramón Bilbao, Itxaso Rica, Luis Antonio Castaño, on behalf of The Spanish Group for the Study of MODY and Type 1 diabetes · 2017 · PLoS ONE
  50. Effects of the genome on immune regulation in type 1 diabetes
    Flemming Pociot, Simranjeet Kaur, Lotte B. Nielsen · 2016 · Pediatric Diabetes
  51. Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset
    A. Robino, Elena Bevilacqua, Luana Aldegheri, Andrea Conti, Valentina Bazzo, G. Tornese, E. Catamo · 2024 · Frontiers in Immunology
  52. Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease
    Jani K. Haukka, Anni A. Antikainen, Erkka Valo, Anna Syreeni, Emma H. Dahlström, Bridget M. Lin, Nora Franceschini, Andrzej S. Królewski, Valma Harjutsalo, Per‐Henrik Groop et al. · 2024 · Diabetologia
  53. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy
    Khalid Siddiqui, Shaik Sarfaraz Nawaz · 2023 · ImmunoTargets and Therapy
  54. A combination of HLA-DP α and β chain polymorphisms paired with a SNP in the DPB1 3’ UTR region, denoting expression levels, are associated with atopic dermatitis
    David J. Margolis, Jamie L. Duke, Nandita Mitra, Ronald Berna, Ole Hoffstad, Jenna R. Wasserman, Amalia Dinou, Georgios Damianos, Ioanna Kotsopoulou, Nikolaos G. Tairis et al. · 2023 · Frontiers in Genetics
  55. Tri-SNP polymorphism in the intron of HLA-DRA1 affects type 1 diabetes susceptibility in the Finnish population.
    Lucas Nygård, A. Laine, M. Kiviniemi, J. Toppari, T. Härkönen, M. Knip, R. Veijola, J. Lempainen, J. Ilonen · 2021 · Human Immunology
  56. Evidence of a plateau in the incidence of type 1 diabetes in children 0–4 years of age from a regional pediatric diabetes center; Auckland, New Zealand: 1977–2019
    Samuel A. Flint, Alistair Jan Gunn, Paul Leslie Hofman, Wayne S. Cutfield, Dug Yeo Han, Fran Mouat, Jinny A. Willis, Craig Jefferies · 2021 · Pediatric Diabetes
  57. Novel Linkage Peaks Discovered for Diabetic Nephropathy in Individuals With Type 1 Diabetes
    J. Haukka, N. Sandholm, E. Valo, C. Forsblom, V. Harjutsalo, Joanne B. Cole, S. McGurnaghan, H. Colhoun, P. Groop · 2021 · Diabetes
  58. Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma
    Hiroki Yamaguchi, Yumika Miyoshi, Yuhei Uehara, Kohei Fujii, Shimpei Nagata, Yoshinari Obata, Motohiro Kosugi, Yoji Hazama, Tetsuyuki Yasuda · 2020 · Diabetology International
  59. A New Pedigree-Based SNP Haplotype Method for Genomic Polymorphism and Genetic Studies
    Zareen Vadva, C. Larsen, Bennett E Propp, Michael R Trautwein, Dennis R. Alford, C. Alper · 2019 · Cells
  60. Association between HLA-DQB1 alleles and susceptibility to coronary artery disease in Southern Han Chinese.
    Yujuan Xiong, Lin Wang, Pei Mo, Guo-Ying Huang, Ai-Qun Li, Ren-Jie Chai, Xiao-Zhen Lin, Yun Zhong, Bin Liu, Wen-qian Ou et al. · 2017 · Human Immunology
  61. A functional framework for interpretation of genetic associations in T1D
    Gerald T. Nepom, Jane Hoyt Buckner · 2012 · Current Opinion in Immunology
  62. Trans-heterodimer between two arthritis non-associated HLA alleles can predispose to arthritis
    Marshall D. Behrens, G. Papadopoulos, A. Moustakas, M. Smart, H. Luthra, C. David, V. Taneja · 2011 · Arthritis & Rheumatism
  63. Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics
    for the TEDDY Study Group, Y Sterner, Carina Törn, H-S Lee, Helena Elding Larsson, Christiane Winkler, Wendy McLeod, Kristian Francis Lynch, Olli Simell, Anette‐Gabriele Ziegler et al. · 2011 · Journal of Perinatology
  64. Immunotherapy in autoimmune type 1 diabetes.
    B. Weigmann, R. K. Franke, C. Daniel · 2012 · The review of diabetic studies : RDS
  65. Type 1 Diabetes Mellitus: Epidemiology, Genetics, Pathogenesis, and Clinical Manifestations
    Omar Ali · 2009 · Springer eBooks
  66. The Impact of HLA-DQαβ Heterodimer Mismatch on Living Donor Kidney Allograft Outcomes
    O. Charnaya, T. Ishaque, A. Hallett, G. P. Morris, Myra Coppage, John L. Schmitz, O. Timofeeva, E. Lázár-Molnár, Ai-Wen Zhang, Scott M. Krummey et al. · 2024 · Transplantation
  67. The effect of type 1 diabetes protection and susceptibility associated HLA class II genotypes on DNA methylation in immune cells
    Sirpa Pahkuri, S. Katayama, Milla Valta, Lucas Nygård, Mikael Knip, J. Kere, J. Ilonen, J. Lempainen · 2024 · HLA
  68. Untangling the genetics of beta cell dysfunction and death in type 1 diabetes
    Catherine C. Robertson, Ruth M. Elgamal, Belle A. Henry-Kanarek, Peter Arvan, Shuibing Chen, Sangeeta Dhawan, Decio Laks Eizirik, John S. Kaddis, Golnaz Vahedi, Stephen C.J. Parker et al. · 2024 · Molecular Metabolism
  69. Autoimmune liver diseases and diabetes
    Anne‐Sofie Houlberg Jensen, Henriette Ytting, Marie Winther‐Sørensen, Johan M. Burisch, Annika M Bergquist, Lise Lotte Gluud, Nicolai J. Wewer Albrechtsen · 2023 · European Journal of Gastroenterology & Hepatology
  70. Autoimmune-associated genetics impact probiotic colonization of the infant gut
    Meghan A. Berryman, Patricia L. Milletich, Joseph R. Petrone, Luiz Fernando Würdig Roesch, Jorma Ilonen, Eric W. Triplett, Johnny Ludvigsson · 2022 · Journal of Autoimmunity
  71. Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4+ T Cells in Type 1 Diabetes
    Perrin Guyer, David Arribas-Layton, Anthony Manganaro, Cate Speake, Sandra M. Lord, Decio Laks Eizirik, Sally C. Kent, Roberto Mallone, Eddie A. James · 2022 · Diabetes
  72. Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical features.
    Maximilian Hoffmann, J. Enczmann, V. Balz, S. Kummer, C. Reinauer, Carsten Doing, Katharina Förtsch, A. Welters, M. K. Vasconcelos, E. Mayatepek et al. · 2022 · Clinical Immunology
  73. Efficacies of programmed cell death 1 ligand 1 blockade in non-small cell lung cancer patients with acquired resistance to prior programmed cell death 1 inhibitor and development of diabetic ketoacidosis caused by two different etiologies: a retrospective case series
    Azusa Ishi, Ichidai Tanaka, Shintaro Iwama, Toshihiro Sakakibara, Toshinori Mastui, Tomoko Kobayashi, Tetsunari Hase, Masahiro Morise, Mitsuo Sato, Hiroshi Arima et al. · 2021 · Endocrine Journal
  74. The association of HLA-DP loci with autoimmune diabetes in Chinese
    Ying Xia, Xia Li, Gan Huang, Jian Lin, Shuoming Luo, Zhiguo Xie, Zhiguang Zhou · 2020 · Diabetes Research and Clinical Practice
  75. Upregulation of FOXO3 in New-Onset Type 1 Diabetes Mellitus
    M. Żurawek, M. Fichna, P. Fichna, M. Czainska, N. Rozwadowska · 2020 · Journal of Immunological Research
  76. Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease
    J. Verhagen, Norkhairin Yusuf, Emma L. Smith, Emily M. Whettlock, Kerina Naran, S. Arif, M. Peakman · 2019 · Diabetologia
  77. Human leucocyte antigens class II allele and haplotype association with Type 1 Diabetes in Madeira Island (Portugal)
    Hélder Spínola, A. Lemos, A. Couto, B. Parreira, M. Soares, I. Dutra, J. Bruges-Armas, António Brehm, S. Abreu · 2017 · International Journal of Immunogenetics
  78. HLA Class II Allele, Haplotype, and Genotype Associations with Type 1 Diabetes in Benin: A Pilot Study
    K. Fagbemi, T. C. M. Medehouenou, Simon Azonbakin, M. Adjagba, R. Osseni, Jocelyne Ahoueya, A. Agbanlinsou, R. Darboux, L. Baba-Moussa, A. Laleye · 2017 · Journal of Diabetes Research
  79. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases
    Anthony C. Y. Yau, F. Piehl, T. Olsson, R. Holmdahl · 2017 · Immunology
  80. Novel diagnostic and therapeutic approaches for autoimmune diabetes — A prime time to treat insulitis as a disease
    Juha Grönholm, Michael J. Lenardo · 2014 · Clinical Immunology
  81. Receiver Operating Characteristic Analysis of HLA, CTLA4, and Insulin Genotypes for Type 1 Diabetes
    A. Valdés, M. Varney, H. Erlich, J. Noble · 2013 · Diabetes Care
  82. Pancreatic atrophy and diabetes mellitus following blunt abdominal trauma
    Mary J. Edwards, David F. Crudo, Terri Lynn Carlson, Anita M. Pedersen, Laura Keller · 2013 · Journal of Pediatric Surgery
  83. Coexistent Autoimmunity in Familial Type 1 Diabetes: Increased Susceptibility in Sib-Pairs?
    Y Lebenthal, M. Yackobovitch-Gavan, L. de Vries, M. Phillip, L. Lazar · 2011 · Hormone Research in Paediatrics
  84. Genetic Determinants of Type 1 Diabetes: Immune Response Genes
    Neeraj Kumar, Gurvinder Kaur, Narinder Kumar Mehra · 2009 · Biomarkers in Medicine
  85. The Co-operative Specificity Theory: phenotypic protection from T1D by certain HLA Class II DRB1 and DQ alleles identifies the absence of co-operation between the respective DR and DQ molecules eventuating in no T1D-predisposition.
    Norbert O Temajo, N. Howard · 2009 · Autoimmunity Reviews
  86. Immune checkpoint inhibitor-associated diabetes mellitus: mechanisms, clinical manifestations, and management strategies
    Yu Chen, Xiaolu Wang, Shuyun Duan · 2026 · Frontiers in Endocrinology
  87. Emerging Biomarkers and Nanobiosensing Strategies in Diabetes
    Anupriya Baranwal, Vipul Bansal, Ravi Shukla · 2025 · Biosensors
  88. Immune checkpoint inhibitors-induced diabetes mellitus (review)
    Jiayi Chen, Xiaochen Hou, Yang Yang, Chenxi Wang, Jie Zhou, Jingge Miao, Fuhong Gong, Fei Ge, Wenlin Chen · 2024 · Endocrine
  89. Association between primary biliary cholangitis with diabetes and cardiovascular diseases: A bidirectional multivariable Mendelian randomization study
    Yun-Lu Lin, Tao Yao, Ying-Wei Wang, Jiasheng Yu, Cheng Zhen, Jiafeng Lin, Shui-Bing Chen · 2024 · Clinics and Research in Hepatology and Gastroenterology
  90. Single locus HLA sequencing with the nanopore technology for HLA disease association diagnosis
    Magali Devriese, Julien Rouquie, Sephora Da Silva, Nadine Benassaya, Lucie Maillard, Mathieu Dewez, Sophie Caillat‐Zucman, Gregory Werner, Jean‐Luc Taupin · 2024 · HLA
  91. Association of human leukocyte antigen (HLA) footprints with the comorbidity of latent autoimmune diabetes in adults (LADA) and hepatitis C virus (HCV) infection: A multicenter cross-sectional study
    Yujin Ding, Pan Zhang, Tuo Deng, Xiang Yan, Min Zhang, Zhiguo Xie, Gan Huang, Ping Wang, Ting Cai, Xiaoli Zhang et al. · 2023 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  92. Characterizing T cell responses to enzymatically modified beta cell neo-epitopes
    Hai P. Nguyen, David Arribas-Layton, I-Ting Chow, C. Speake, W. Kwok, M. Hessner, C. Greenbaum, E. James · 2023 · Frontiers in Immunology
  93. Precision Medicine in Type 1 Diabetes
    Dominika A. Michalek, Suna Önengüt-Gümüşcü, David R. Repaske, Stephen S. Rich · 2023 · Journal of the Indian Institute of Science
  94. Sintilimab-induced autoimmune diabetes: A case report and review of the literature
    Jing Yang, Ying Wang, Xiang-Min Tong · 2022 · World Journal of Clinical Cases
  95. Genome-wide discovery for diabetes-dependent triglycerides-associated loci
    M. Selvaraj, K. Paruchuri, S. Haidermota, R. Bernardo, S. Rich, G. Peloso, P. Natarajan · 2022 · medRxiv
  96. The Unfavorable Impact of DR9/DR9 Genotype on the Frequency and Quality of Partial Remission in Type 1 Diabetes
    Yan Chen, Ying Xia, Zhiguo Xie, Ting Zhong, Rong Tang, Xia Li, Zhiguang Zhou · 2021 · The Journal of Clinical Endocrinology & Metabolism
  97. Segregation Analysis of Genotyped and Family-Phased, Long Range MHC Classical Class I and Class II Haplotypes in 5 Families With Type 1 Diabetes Proband in the United Arab Emirates
    Guan K. Tay, Halima Al Naqbi, A. Mawart, Zahrah Baalfaqih, Anoud Almaazmi, A. Deeb, Habiba S. Alsafar · 2021 · Frontiers in Genetics
  98. Genetics of canine diabetes mellitus part 2: Current understanding and future directions
    Alice L. Denyer, Briän Catchpole, Lucy J. Davison · 2021 · The Veterinary Journal
  99. Diabetes and Genetics: A Relationship Between Genetic Risk Alleles, Clinical Phenotypes and Therapeutic Approaches
    Shomoita Sayed, A.H.M. Nurun Nabi · 2020 · Advances in experimental medicine and biology
  100. Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
    Chandrabose Selvaraj, Gurudeeban Selvaraj, Satyavani Kaliamurthi, William Chi Shing Cho, Dong‐Qing Wei, Sanjeev Kumar Singh · 2019 · Current Drug Targets